SCHEMBL5873130

SCHEMBL5873130

O=C(c1cc(Br)cc(Br)c1)C(Br)C(Br)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.41
CES1 P23141 2/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 2/20 0.41
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
S1PR3 Q99500 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
ALOX15 P16050 1/20 0.37
HTT P42858 1/20 0.37
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
GPR139 Q6DWJ6 1/20 0.36
CYP1A2 P05177 1/20 0.36
FPR2 P25090 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5873120 0.87 ALDH1A1 (0.52) CES2CES1ALDH1A1LMNATDP1
SCHEMBL5873117 0.86 LMNA (0.50) CES2CES1ALDH1A1LMNATDP1
SCHEMBL978025 0.83 TDP1 (0.57) CES2CES1ALDH1A1LMNATDP1
SCHEMBL28795688 0.82 MEN1 (0.50) CES2CES1ALDH1A1LMNATDP1
SCHEMBL1794536 0.79 PARP1 (0.50) CES2CES1ALDH1A1L3MBTL1KMT2A
SCHEMBL1795647 0.78 PARP1 (0.49) ALDH1A1L3MBTL1KMT2AMEN1NPC1
SCHEMBL1799408 0.78 PARP1 (0.41) CES2CES1ALDH1A1LMNATDP1
SCHEMBL28795612 0.77 CES2 (0.50) CES2CES1ALDH1A1LMNATDP1
SCHEMBL28795622 0.76 CES2 (0.48) CES2CES1ALDH1A1LMNATDP1
SCHEMBL5873189 0.76 CES2 (0.48) CES2CES1ALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067702-B2 Process for preparing vinyl substituted beta-diketones THE JOHNS HOPKINS UNIVERSITY (US) 2006-06-27 US disclosed
US-20060069288-A1 Process for preparing vinyl substituted beta-diketones THE JOHNS HOPKINS UNIVERSITY 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069288-A1 Process for preparing vinyl substituted beta-diketones VRK1, VRK2, DEK CES2 2479/4885CES1 2307/4885ALDH1A1 2757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.